Live · 13 Sep 2026 SPX 7,656.98 +0.86% NDX 29,368.44 +0.91% VIX 15.84 -11.21% GOLD 4,390.00 +0.58% CL 99.99 -2.43% BTC 77,135.67 +0.74%
NAS100 29,368 +0.91% S&P 7,657 +0.86% GOLD $4,390 +0.58% BTC $77,136 +0.74% VIX 15.84 −11.21% live tape · as of 10:31 UTC
Vol. II · No. 256Sunday, 13 September 2026
TTitan Protect
The Screen · Healthcare · Health Information Services

LifeMD, Inc.

LFMDP · Nasdaq · USD · 347 employees

LifeMD, Inc.

FAIL · Does not pass the screen
23.33 USD

At the last full screen
2025-12-31

Screened 2025-12-31 · the tape above runs as of 10:31 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

The Label · The Season, Not the Day

This name holds its markdown label.

LifeMD, Inc. holds its Markdown at $23.33. Consolidating, no directional conviction, held for 2 days.

As held on the ledger · 2025-12-31
PhaseMarkdown · caution
Quantitative stateConsolidating, no directional conviction, held for 2 days
Price at the screen$23.33
ValuationN/A trailing · N/A forward price to earnings
Values screenFAIL · score 70.0
Beta1.99
The Workings

Five Screens, Shown in Full

Does not pass. Accounts receivable

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 8.98% Below 33% Interest-bearing debt is just 9.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 65.46% Below 49% Money owed to the company is 65.5% of assets, above the 49% limit. Fail
Revenue purity 0.00% Below 5% Only 0.0% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Business, in Plain Words
The fundamentals · plain-English read
EPS, trailing-2.26
Revenue growth-1.4%revenue is shrinking
Profit margin2.9%barely profitable
Return on equity-238.5%not currently earning a positive return on equity
Dividend yield950.00%
Debt to equity0.41minimal debt: a conservative balance sheet
Current ratio1.04adequate liquidity, worth monitoring
Beta1.99much more volatile than the market
52-week range18.50 - 24.34
Employees347

The risks · The things to watch: it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

LFMDP trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-09-04 Accumulation · changed $23.33 +0.0% Entry 5

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-08-04 Markdown · changed $23.33 -0.2% Entry 4

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-07-18 Accumulation $23.36 +0.0% Entry 3

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 11%. Our forward projection puts the odds of a 10% gain over the next month near 16%.

2026-07-03 Accumulation $23.36 +0.0% Entry 2

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

2026-07-02 Accumulation $23.36 Entry 1

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in LFMDP's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $23.73 +1.0% · $1,010 +1.0%
2 months $23.80 +0.7% · $1,007 +0.7%
3 months $22.40 +7.0% $0.56 $1,094 +9.4%
6 months $21.55 +11.2% $1.11 $1,163 +16.3%
1 year $21.55 +11.2% $2.22 $1,215 +21.5%
2 years $18.76 +27.7% $4.44 $1,514 +51.4%
3 years $12.27 +95.2% $6.66 $2,495 +149.5%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever LFMDP does next, these words stay.

LifeMD, Inc. · LFMDP · Markdown · $23.33
Recorded 2025-12-31 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.